Literature DB >> 31165249

High-fat diet induced central adiposity (visceral fat) is associated with increased fibrosis and decreased immune cellularity of the mesenteric lymph node in mice.

Aaron M Magnuson1, Daniel P Regan2, Andrea D Booth1, Josephine K Fouts1, Claudia M Solt1, Jessica L Hill1, Steve W Dow2, Michelle T Foster3.   

Abstract

PURPOSE: Accumulation of visceral, but not subcutaneous, adipose tissue is highly associated with metabolic disease. Inflammation inciting from adipose tissue is commonly associated with metabolic disease risk and comorbidities. However, constituents of the immune system, lymph nodes, embedded within these adipose depots remain under-investigated. We hypothesize that, lymph nodes are inherently distinct and differentially respond to diet-induced obesity much like the adipose depots they reside in.
METHODS: Adipose tissue and lymph nodes were collected from the visceral and inguinal depots of male mice fed 13 weeks of standard CHOW or high fat diet (HFD). Immune cells were isolated from tissues, counted and characterized by flow cytometry or plated for proliferative capacity following Concanavalin A stimulation. Lymph node size and fibrosis area were also characterized.
RESULTS: In HFD fed mice visceral adipose tissue accumulation was associated with significant enlargement of the lymph node encased within. The subcutaneous lymph node did not change. Compared with mice fed CHOW for 13 weeks, mice fed HFD had a decline in immune cell populations and immune cell proliferative ability, as well as, exacerbated fibrosis accumulation, within the visceral, but not subcutaneous, lymph node.
CONCLUSIONS: Obesity-induced chronic low-grade inflammation is associated with impaired immunity and increased susceptibility to disease. Excessive visceral adiposity and associated inflammation driven by diet likely leads to obesity-induced immune suppression by way of lymph node/lymphatic system pathophysiology.

Entities:  

Keywords:  Central obesity; Lymphatics; Metabolic disease; Pro-inflammation; Visceral adiposity

Mesh:

Year:  2019        PMID: 31165249      PMCID: PMC6891137          DOI: 10.1007/s00394-019-02019-z

Source DB:  PubMed          Journal:  Eur J Nutr        ISSN: 1436-6207            Impact factor:   5.614


  46 in total

Review 1.  Adipose tissue remodeling and obesity.

Authors:  Kai Sun; Christine M Kusminski; Philipp E Scherer
Journal:  J Clin Invest       Date:  2011-06-01       Impact factor: 14.808

Review 2.  Subcutaneous and visceral adipose tissue: structural and functional differences.

Authors:  M Mohsen Ibrahim
Journal:  Obes Rev       Date:  2009-07-28       Impact factor: 9.213

3.  Reduced adipose tissue lymphatic drainage of macromolecules in obese subjects: a possible link between obesity and local tissue inflammation?

Authors:  N Arngrim; L Simonsen; J J Holst; J Bülow
Journal:  Int J Obes (Lond)       Date:  2012-07-03       Impact factor: 5.095

Review 4.  Review article: lymphatic system and associated adipose tissue in the development of inflammatory bowel disease.

Authors:  P-Y von der Weid; K J Rainey
Journal:  Aliment Pharmacol Ther       Date:  2010-09       Impact factor: 8.171

5.  Jejunal mucosal injury and restitution: role of hydrolytic products of food digestion.

Authors:  P R Kvietys; R D Specian; M B Grisham; P Tso
Journal:  Am J Physiol       Date:  1991-09

6.  Hypoxia-inducible factor 1alpha induces fibrosis and insulin resistance in white adipose tissue.

Authors:  Nils Halberg; Tayeba Khan; Maria E Trujillo; Ingrid Wernstedt-Asterholm; Alan D Attie; Shariq Sherwani; Zhao V Wang; Shira Landskroner-Eiger; Sean Dineen; Ulysses J Magalang; Rolf A Brekken; Philipp E Scherer
Journal:  Mol Cell Biol       Date:  2009-06-22       Impact factor: 4.272

Review 7.  Modulation of intestinal immune system by dietary fat intake: relevance to Crohn's disease.

Authors:  S Miura; Y Tsuzuki; R Hokari; H Ishii
Journal:  J Gastroenterol Hepatol       Date:  1998-12       Impact factor: 4.029

8.  Intestinal dendritic cells specialize to activate transforming growth factor-β and induce Foxp3+ regulatory T cells via integrin αvβ8.

Authors:  John J Worthington; Beata I Czajkowska; Andrew C Melton; Mark A Travis
Journal:  Gastroenterology       Date:  2011-06-30       Impact factor: 22.682

Review 9.  Obesity as a major risk factor for cancer.

Authors:  Giovanni De Pergola; Franco Silvestris
Journal:  J Obes       Date:  2013-08-29

10.  Intestinal CD103+, but not CX3CR1+, antigen sampling cells migrate in lymph and serve classical dendritic cell functions.

Authors:  Olga Schulz; Elin Jaensson; Emma K Persson; Xiaosun Liu; Tim Worbs; William W Agace; Oliver Pabst
Journal:  J Exp Med       Date:  2009-12-14       Impact factor: 14.307

View more
  4 in total

Review 1.  The Role of Aberrant Metabolism in Cancer: Insights Into the Interplay Between Cell Metabolic Reprogramming, Metabolic Syndrome, and Cancer.

Authors:  Yina Yu; Liang Gong; Jun Ye
Journal:  Front Oncol       Date:  2020-06-11       Impact factor: 6.244

2.  Dietary lipids accumulate in macrophages and stromal cells and change the microarchitecture of mesenteric lymph nodes.

Authors:  Katharina Streich; Margarethe Smoczek; Jan Hegermann; Oliver Dittrich-Breiholz; Melanie Bornemann; Anja Siebert; Andre Bleich; Manuela Buettner
Journal:  J Adv Res       Date:  2020-04-29       Impact factor: 10.479

3.  Decrease in the Size of Fat-Enlarged Axillary Lymph Nodes and Serum Lipids after Bariatric Surgery.

Authors:  Dennis Dwan; Seth K Ramin; Youdinghuan Chen; Kristen E Muller; Roberta M diFlorio-Alexander
Journal:  Cells       Date:  2022-01-30       Impact factor: 6.600

Review 4.  Gut Microbiome and Organ Fibrosis.

Authors:  Carolina F F A Costa; Benedita Sampaio-Maia; Ricardo Araujo; Diana S Nascimento; Joana Ferreira-Gomes; Manuel Pestana; Maria J Azevedo; Ines S Alencastre
Journal:  Nutrients       Date:  2022-01-14       Impact factor: 5.717

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.